References
- Nowell P C, Hungerford D A. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1197–1200
- Rowley J D. A new consistent abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293
- Benacerraf B. Role of MHC gene products in immune regulation. Science 1981; 212: 1229–1238
- Tiwari J L, Terasaki P I. HLA and disease associations. Springer Verlag, New York, NY 1985; 71–72
- Buzyn A, Ostankovitch M, Zerbib A, Kemula M, Connan F, Varet B, et al. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes. Eur J Immunol 1997; 27: 2066–2072
- Caruso C, Lo Campo P, Botindari C, Modica M A. HLA antigens in Sicilian patients affected by chronic myelogenous leukemia. J Immunogenet 1987; 14: 295–299
- Bortin M M, D'Amaro J, Bach F H, Rimm A A, van Rood J J. HLA associations with leukemia. Blood 1987; 70: 227–232
- D'Amaro J, Bach F H, van Rood J J, Rimm A A, Bortin M M. HLA-C associations with acute leukemia. Lancet 1984; 2: 1176–1178
- Rosas-Cabral A, Irigoyen L, Alvardo L, Vela-Ojeda J, Ayala-Sanchez M, Tripp-Villanueva F, et al. HLA-Cw3 and HLA-Cw4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients. Rev Invest Clin 2003; 55: 423–428
- Posthuma E F, Falkenburg J H, Apperley J F, Gratwohl A, Roosnek E, Herstein B, et al. HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The chronic leukemia Working Party of the EBMT. Blood 1999; 93: 3863–3865
- Posthuma E F, Falkenburg J H, Apperley J F, Gratwohl A, Hertenstein B, Schipper R F, et al. HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry. Leukemia 2000; 14: 859–862
- Yasukawa M, Ohminami H, Kojima K, Inokuchi K, Nishimura Y, Fujita S. Analysis of HLA-DRB1 alleles in Japanese patients with chronic myelogeous leukemia. Am J Hematol 2000; 63: 99–101
- Chiewsilp P, Sujirachato K, Mongkolsuk T, Junpong S, Jootar S, Hathirat P. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais. J Med Assoc Thai 2000; 83(Suppl 1)S130–S136
- Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976, Suppl 5: 9–15
- Terasaki P I, McClelland J D. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998–1000
- Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251–253
- Haldane J BS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 309–311
- Dunn O J. Multiple comparison among means. Am J Stat Assoc 1961; 56: 52–56
- Mundhada S, Luthra R, Cano P. Association of HLA class I and class II genes with bcr-abl transcripts in leukemia patients with t(9,22)(q34,q11). BMC Cancer 2004; 4: 25–29
- Kuruvilla J, Gupta V, Gill K S, Lipton J H. Association of familial leukemia with HLA Cw3: is it real?. Leuk Lymphoma 2003; 44: 309–311
- Mueller L P, Machulla H KG. Increased frequency of homozygosity for HLA class II loci in female patients with chronic lymphocytic leukemia. Leuk Lymphoma 2002; 43: 1013–1019
- Rajalingam R, Mehra N K, Mehra R D, Neolia S, Jain R C, Pande J L. HLA class I profile in Asian Indian patients with pulmonary tuberculosis. Indian J Exp Biol 1997; 35: 1055–1059
- Ravikumar M, Dheenadhayalan V, Rajaram K, Lakshmi S S, Kumaran P P, Paramasivan C N, et al. Association of HLA DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in South India. Tuber Lung Dis 1999; 79: 309–317
- Carcino L, Sorrentino R, Tosi R. Strong genetic association between HLA-DR3 and a polymorphic variation in the regulatory region of the HSP 70-1 gene. Immunogenetics 1993; 37: 177–182
- Dorak M T, Chalmers E A, Gaffney D, Wilson D W, Galbraith I, Henderson N, et al. Human major histocompatibility complex contains several leukemia susceptibility genes. Leuk Lymphoma 1994; 12: 211–222
- Oguz F S, Kalayoglu S, Difer A S, Tozkir H, Sargin D, Carin M, et al. HLA system affects the age-at-onset in chronic myeloid leukemia. Am J Hematol 2003; 73: 256–262
- Chhaya S U, Panthaki M, Shankarkumar U. HLA antigen distribution in Gujarati speaking Hindu population from Mumbai, Maharashtra, India. Anthropologist 2000; 2: 7–12
- Chhaya S U, Shankarkumar U. HLA antigen distribution in Jain population from Mumbai, Maharashtra, India. Indian J Med Res 2001; 114: 25–29
- Chhaya S U, Shankarkumar U. HLA antigen distribution in selected Gujarati subcaste from Mumbai, Maharashtra, India. Int J Hum Genet 2003; 3: 135–138
- Rozemuller E H, Mehra N K, Vander Zwan A W, Jaini R, Tilanus M GJ. HLA A*3306 a novel variant in the Indian population. Tissue Antigens 2002; 59: 421–423
- Kankonkar S, Jeyanti G, Singhal B S, Shankarkumar U. Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India. Hum Immunol 2003; 64: 478–482
- Shankarkumar U, Devraj J P, Ghosh K, Mohanty D. Seronegative spondarthropathies and human leukocyte antigen associations. Br J Biomed Sci 2002; 59: 38–41